Clinical experience with ceftazidime for lower respiratory tract infections.
De Sandre
G
G
Istituto di Patologia Speciale Medica-II, Università di Padova, Verona, Italy.
Corrocher
R I
RI
Gabrielli
G B
GB
Ho
I
I
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001772:Blood Cell Count; D002442:Ceftazidime / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012882:Skin Tests
D000900:Anti-Bacterial Agents; D002442:Ceftazidime